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RNA editing by adenosine deaminases that act on RNA converts adenosines to inosines
in coding and non-coding regions of mRNAs. Inosines are interpreted as guanosines and
hence, this type of editing can change codons, alter splice patterns, or influence the fate of
an RNA. A to I editing is most abundant in the central nervous system (CNS). Here, targets
for this type of nucleotide modification frequently encode receptors and channels. In many
cases, the editing-induced amino acid exchanges alter the properties of the receptors and
channels. Consistently, changes in editing patterns are frequently found associated with
diseases of the CNS. In this review we describe the mechanisms of RNA editing and
focus on target mRNAs of editing that are functionally relevant to normal and aberrant
CNS activity.
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RNA EDITING
RNA editing is a site specific, post transcriptional modification
of RNA. Two types of RNA editing can be distinguished. On the
one hand, insertion-deletion type editing inserts or removes sin-
gle or multiple nucleotides from an RNA molecule (Simpson et al.,
2000). This type of editing is mostly found in organelles of various
phyla. Deamination type editing, on the other hand, changes the
identity of a base by deaminating cytidine to uracil or adenosine to
inosine, respectively (Carter, 1995). Deamination type editing has
been found in all kingdoms of life. Deamination of cytidines was
first discovered in the mRNA encoding apolipoprotein B which
is deaminated by Apobec1 a member of the apobec/AID cytidine
deaminase family that mostly target cytidines in DNA. Recently,
abundant cytidine deamination by Apobec1 was identified in
the 3′ UTRs of many mouse mRNAs (Rosenberg et al., 2011).
The function of these editing events remains to be determined,
however.
Adenosine deamination by adenosine deaminases that act on
RNA (ADAR) seemingly only affects metazoan nuclear encoded
RNAs. Deamination of adenosines leads to the formation of
inosines which are recognized as guanosines by most cellular
machineries (Bass and Weintraub, 1988). Editing in coding regions
of mRNAs can therefore lead to a codon exchange and the sub-
sequent translation of a protein that differs from the genomically
encoded version. Moreover, editing can also introduce or remove
splice sites and thereby lead to the formation of novel mRNAs
(Rueter et al., 1999). Finally, inosines in RNA can change the base-
pairing propensity of an RNA and therefore alter their folding
and change their signature for RNA-binding proteins (Nishikura,
1992). Thus, also editing in non-translated regions of an mRNA
may have profound impact on the fate of the affected RNA. Besides
mRNAs, also primary and precursor miRNAs can be targets for
RNA editing by ADARs. Editing of pri- and pre-miRNAs can alter
their processing but also their base-pairing potential with target
mRNAs. Therefore, editing of miRNAs can indirectly change the
abundance and translatability of their target mRNAs.
Editing of mRNAs was originally believed to be a rare event.
In recent years, however, editing was found to be widespread in
mRNAs of higher eukaryotes (Athanasiadis et al., 2004; Levanon
et al., 2004). In all organisms editing by ADARs is most abundant
in the nervous system. The profound alterations of the transcrip-
tome and proteome introduced by RNA editing may thus help to
solve a long lasting biological paradigm, namely, how biological
complexity can be achieved with an almost constant number of
genes: editing-induced alterations of splice patterns and coding
potential of mRNAs may, together with alternative splicing, con-
tribute to the formation of a complex proteome from a limited
number of genes. Consistently, alterations in the editing patterns
or loss of editing is accompanied by pathologic conditions and
disease (Morabito and Emeson, 2009).
THE ADAR PROTEIN FAMILY
ADARs were first discovered in Xenopus laevis as an unwind-
ing activity that destabilizes RNA duplexes upon A to I editing
(Bass and Weintraub, 1987; Rebagliati and Melton, 1987). ADARs
have been well characterized in many organisms including insects,
worms, and vertebrates (Bass, 2002). The first ADAR gene identi-
fied was vertebrate ADAR1 harboring three double-stranded RNA-
binding domains (dsRBDs) and a conserved deaminase domain
with zinc binding motifs. Subsequent screens led to the identifica-
tion of ADAR2 (Melcher et al., 1996; O’Connell et al., 1997). Recent
analyses have shown the presence of ADAR1 and ADAR2 in many
species including sea urchin and sea anemones (Jin et al., 2009).
The vertebrate genome encodes two additional, ADAR proteins.
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ADAR3, which presumably arose from ADAR2 by gene duplica-
tion, contains all functional domains. However, no function has
been ascribed to this isoform (Chen et al., 2000). The fourth
ADAR-like gene, termed TENR, is expressed in the male germ line
and has one dsRBD. TENR lacks conserved zinc chelating residues
in the deaminase domain thus explaining its inactivity (Hough
and Bass, 1997). ADARs are related to the tRNA editing family of
ADATs which are found in all kingdoms of life (Jin et al., 2009).
PHENOTYPES OF ADAR DEFICIENCY
Different phenotypes are associated with the lack of individual
ADAR isoforms. ADAR2 null mice have episodes of epileptic
seizures and show subsequent postnatal death. A key substrate of
ADAR 2 is the mRNA encoding GluA2. Underedited GluA2 allows
increased influx of Ca2+ leading to death of neurons (Brusa et al.,
1995). Consistently, ADAR2−/−mice can be rescued by replac-
ing the genomic, unedited GluA2 copy with a “preedited” gene
copy (Higuchi et al., 2000). Still, even the rescued ADAR2−/−mice
display a range of subtle phenotypes ranging from a decreased
acoustic startle response to decreased blood glucose level. The
molecular mechanisms underlying these changes are still to be
determined (Horsch et al., 2011). ADAR2 overexpressing mice,
in contrast, display hyperphagia and obesity (Singh et al., 2007).
This phenotype can be reproduced by a catalytically inactive ver-
sion of ADAR2 that retains its RNA-binding ability. This suggests
that RNA binding of ADARs can lead to editing-independent
phenotypes (Singh et al., 2007).
Mice lacking ADAR1 die during embryonic development, show
defective hematopoiesis, widespread apoptosis, and liver disinte-
gration (Hartner et al., 2004). Molecularly, ADAR1 deficient mice
show an increase in interferon signaling with the precise molecular
mechanisms leading to death remaining unknown (Hartner et al.,
2009).
In Drosophila melanogaster inactivation of the single ADAR
gene causes tremors, lack of coordination, mating defects, and
neurodegeneration presumably resulting from underediting of
important dADAR target genes such as Na+ (para), Ca2+(cac),
and glutamate-gated Cl− channels (DrosGluCl-α; Palladino et al.,
2000). Caenorhabditis elegans strains with homozygous deletions
in either of the two ADARs adr-1 or adr-2 show chemotactic
defects, also indicating a role in the editing of neuronally expressed
substrates (Tonkin et al., 2002).
SUBSTRATES OF ADAR
RNA editing by adenosine deaminases can affect coding and non-
coding RNA sequences. Substrate RNAs are recognized by the
dsRBDs located in ADARs. These domains bind to A-form helices
formed by double-stranded RNAs. Thus, editing sites are defined
by base-paired regions of 20 or more nucleotides in length. A-
form helices display a wide minor groove and a narrow major
groove. Sequence specific information of the bases cannot be eas-
ily contacted making a sequence specific positioning of ADARs
difficult (Ryter and Schultz, 1998). Still, various mechanisms can
contribute to substrate and editing specificity. Multiple dsRBDs
found in ADARs can coordinately bind to substrates (Stefl et al.,
2005). Most double-stranded structures formed by endogenous
RNAs are disrupted by bulges. These bulges set natural boundaries
for the binding of dsRBDs (Lehmann and Bass, 1999). If two or
more dsRBDs need to bind to a double-stranded region of limited
length they can help to position each other. Structural analysis of
ADAR2 bound to a stem loop substrate shows nicely that some
dsRBDs can also bind to terminal loops thus helping to increase
substrate specific binding (Stefl et al., 2006). Recently, specific
minor groove interactions between dsRBDs and nucleotides have
been identified. These interactions can increase sequence speci-
ficity dramatically, therefore aiding in selecting specific adenosines
within a stretch of double-stranded RNA (Stefl et al., 2010).
Finally, also the deaminase domains of ADAR1 and ADAR2 display
substrate specificities that preferentially select certain adenosines
depending on their local sequence context (Polson and Bass, 1994;
Eggington et al., 2011). As the adenosine to be edited typically lies
within a double-stranded structure the target adenosine needs to
be accessed through a base flipping mechanism (Stephens et al.,
2000; Yi-Brunozzi et al., 2001).
The altered base-pairing potential of inosines can lead to an
alteration of the RNA secondary structure. Thus, editing in the
non-translated regions of mRNAs may alter their localization, sta-
bility, and translatability. However, the biological consequences
of editing in these targets is still under debate. The consequences
of adenosine deamination in coding regions of mRNAs and pri-
miRNAs on the other hand are more easy to understand. As
inosines are read as guanosines during translation, inosines can
alter the coding potential or targeting specificity of mRNAs and
miRNAs, respectively (Vesely et al., 2012).
The proteins encoded by edited pre-mRNAs vary widely in
their function. However, frequently editing-induced amino acid
exchanges affect receptors and ion channels expressed in the brain.
Another class of proteins affected by RNA editing play a role in
cytoskeletal remodeling which also plays an important role in
neuronal outgrowth and plasticity. In the following, represen-
tative examples of both classes of proteins and the functional
implications of their editing will be described.
GLUTAMATE-GATED ION CHANNELS
Five subunits of the glutamate receptor (GluA2, GluA3, GluA4,
GluK1, and GluK2) are found to undergo ADAR-mediated RNA
editing (Bass,2002). A total of four editing sites that result in amino
acid changes have been identified, namely glutamine to arginine
(Q/R), arginine to glycine (R/G), isoleucine to valine (I/V), and
tyrosine to cysteine (Y/C; see Table 1).
AMPA GluA2 subunit mRNA was the first target discovered.
It is edited mainly at two coding sites leading to a glutamine to
arginine and arginine to glycine conversion (Sommer et al., 1991;
Lomeli et al., 1994; see Figure 2).
Two additional editing sites are found in intron 11 of
GluA2 mRNA, called hotspot 1 (or +60 site) and hotspot 2
(or+262/263/264 site), respectively (Higuchi et al., 1993). Edit-
ing at the Q/R site reduces Ca2+ permeability (see Figure 1). The
edited GluA2R isoforms also show reduced endoplasmic reticulum
(ER) exit efficiency, whereas unedited GluA2Q isoforms readily
tetramerize and are transported to the synaptic membrane (Greger
et al., 2002, 2003). GluA2 in the unedited Q form leads to epilep-
tic seizures and subsequent postnatal death. This toxic effect has
been attributed to increased calcium influx (Higuchi et al., 2000).
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Table 1 | Selected editing events in the CNS.
Target Editing site Function Diseases
GluA2 Q607 R Calcium impermeable ER exit efficiency reduction ALS, epilepsy, glioblastomamultiforme, pediatric
astrocytoma
GluA2 R764G Enhanced rate of desensitization Spinal cord injury (SCI), epilepsy




I156V Modulation of surface expression of the receptor Schizophrenia
I156M Reduced G protein coupling Bipolar disorder




Kv1.1 I400V Faster recovery from inactivation Epilepsy
Reduced potency of channel blockers
GABAA I342M Reduced stability of α3 subunit Migraine
FLNa Q2341R Binds to: Kv4.2 K+ Channel
Presenilins metabotropicmGlu5a/b, mGlu7b, mGlu8a, weak:
mGlu7a mGlu4a
CyFIP2 K320E
Nova-1 S383G Increase in protein stability
Ca(v)1.3 I1606M Decrease in calmodulin mediated calcium dependent
inhibition (CDI) and faster recovery from inactivationQ1607R
Y1609C
Proposed physiological and pathological consequences.
Additionally increased receptor density due to faster ER exit may
also contribute to this effect (Greger et al., 2002; see Figure 1).
The R/G conversion reduces the assembly of homomeric recep-
tors and slows down receptor maturation in the ER (Greger et al.,
2006). Additionally, R/G site editing results in enhanced recovery
from desensitization (Lomeli et al., 1994). Editing events in the
GluA2 pre-mRNA also affect splicing of nearby introns. Editing
at the R/G site of GluA2 takes place two nucleotides upstream
of the 5′ splice site in intron13. The Q/R site is located in exon
11, 25 nucleotides upstream of the 5′ splice site of intron 11
(Higuchi et al., 1993). Editing at the Q/R site and the intronic
hotspot enhances splicing of the nearby intron, while editing at
the R/G site represses splicing at the downstream intron (Schoft
et al., 2007). Editing at the R/G site may affect base-pairing of the
pre-mRNA with the U1snRNA (Schoft et al., 2007). R/G site edit-
ing also influences the alternative splicing of the two downstream
exons as editing promotes inclusion of exon15 (flip) over exon14
(flop). GluA2 protein with an edited G and the flip variant under-
goes rapid maturation in the ER relative to the flop form. The flip
variant also stimulates dendritic growth (Hamad et al., 2011). The
flop isoform, in turn, promotes assembly of heteromeric AMPA
receptors (Penn and Greger, 2009).
Also kainate receptor subunits GluK1 and -2 are edited at the
Q/R position. GluK2 undergoes additional editing at the I/V and
Y/C sites, located at positions 621, 567, and 571 respectively, which
may lead to higher calcium permeability (Kohler et al., 1993).
GABAA RECEPTOR
GABAA receptors are ligand gated chloride channels consisting
of five subunits: 2 α subunits, 2 β subunits, and either a γ or a
δ subunit (Hevers and Luddens, 1998). The existence of 6 α, 3
β, 3 γ, and 4 δ subunits allows for the assembly of a wide vari-
ety of stoichometries. Position 342 of the α3 subunit is highly
edited, resulting in an isoleucine (AUA) to methionine (AUI)
codon change (Ohlson et al., 2007; see Figure 2). The editing site is
defined by a specific RNA structure marked by bulges at a defined
distance from the editing site as well as a specific terminal loop
structure (Tian et al., 2011). With age, the two α subunits show
opposing expression patterns. While α1 expression increases with
age the α3 subunit is predominant at embryonic level (Hutcheon
et al., 2004). Moreover, editing is developmentally regulated. The
pre-mRNA is mostly found unedited around day e15 but is edited
from 80% to 100% at postnatal day 7 (p7; Ohlson et al., 2007; Rula
et al., 2008)
The I/M change in GABAA receptor causes a delay in currents
and faster deactivation upon stimulation by GABA (Rula et al.,
2008). Expression of unedited GABAA receptor in the develop-
ing brain is crucial for synapse formation (Ben-Ari et al., 2007).
Recently, editing has been proposed to affect the stability of the
α3 subunit as the edited version displays low cell surface expres-
sion. The M version of the receptor maintains the hydrophobic
environment but can influence the interaction between α and γ
subunits or ligand interaction (Daniel et al., 2011; see Table 1;
Figure 1).
VOLTAGE-GATED POTASSIUM CHANNELS
Neuronal Kv1.1 channels are built of a tetramer of pore forming
α subunits along with four regulatory beta subunits and acces-
sory subunits. The channels regulate action potential and modu-
late neuronal excitability by opening and closing of a potassium
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FIGURE 1 | Impact of editing on selected neuronal receptors and
proteins. Shown are several receptors and channels in their unedited (black)
and edited (E, in pink) versions. Editing at the Q/R site of ionotropic glutamate
receptor GluA2 subunit decreases Ca2+permeability and endoplasmic
reticulum exit efficiency. Membrane trafficking of the GABAA receptor is
reduced by editing of I to M in the alpha3 subunit. Editing of the serotonin
5-HT2c receptor converts the amino acids I-N-I to V-S-V or V-N-V. This reduces
G-protein coupling in the receptor. The editing-induced I to V exchange in Kv1.1
(I/V) alters the interaction with Kv β1.1 (see Figure 3 for detail). Editing of the
IQ motiv in Cav1.3 to MR abolishes calmodulin binding. Filamin alpha (FLNa) is
edited in a region that is known to interact with metabotropic glutamate
receptor mGlu7b and some of its relatives.
selective pore. The human Kv1.1 (KCNA1) gene is intronless and
undergoes A to I RNA editing leading to an isoleucine to valine
exchange (see Figure 1). The amino acid exchange is located within
the sixth transmembrane segment (S6) which lies at the ion con-
ducting pore (Bhalla et al., 2004; see Figure 2). Kv1.1 channels
are edited up to 65–80% in medulla, thalamus and spinal cord
(Decher et al., 2010). The I–V change is evolutionarily conserved
and also occurs in Kv2 (DmShab Shaker) channels in Drosophila
melanogaster together with four other editing events (Bhalla et al.,
2004; Ryan et al., 2008).
Kv1.1 associates with the redox sensor Kv β1 in the ER (Pan
et al., 2008). Kv β harbors an N-terminal inactivation domain that
controls inactivation and lag time of Kv1.1. The edited Kv1.1 shows
a 20 fold higher recovery from Kv β1 mediated inactivation than
the unedited version of the channel (Bezanilla, 2004; Bhalla et al.,
2004; see Figure 3).
The Kv channel blocker 4-aminopyridine (4-AP) has been
shown to induce epileptic seizures. RNA editing makes the chan-
nel insensitive to 4-AP by disrupting the interaction between the
pore lining and the channel blocker (see Table 1; Streit et al.,
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FIGURE 2 |Topography of the neuronal channels containing editing sites Ionotropic glutamate receptor, GABAA receptor subunit α3, Kv1.1, Cav1.3,
and 5-HT2c receptors are shown. The relative position of the editing sites within these receptors are highlighted. Consequences of editing are indicated.
FIGURE 3 | Regulation of the Kv1.1 channel by Kv β1.1 Kv β1.1
has an inactivation gate which interacts with the unedited (I)
form of the Kv1.1 receptor. Editing of Kv1.1 changes the
isoleucine to valine (V). This reduces the affinity for Kv β1.1 and
enhances recovery from inactivation. Figure adapted from
(Bezanilla, 2004).
2011). A similar insensitivity was observed against arachidonic
acid (Decher et al., 2010).
Squid Kv 1.1A has also been shown to be extensively edited
(Rosenthal and Bezanilla, 2002). Here editing not only affects
channel gating but also influences the tetramerization of the
channel.
VOLTAGE-GATED CALCIUM CHANNELS
Voltage-gated calcium channels (VGCC) are classified into two
types: Low voltage activated (LVA) and High voltage activated
(HVA) channels (Lacinova, 2005). LVA l-type calcium channels
are involved in a broad range of neuronal processes such as neu-
ronal pacemaking, secretion of neurotransmitters, synaptic trans-
mission, mRNA stability, and modulation of other ion channels
(Singh et al., 2008). The opening of these channels permits calcium
influx. The channels are inactivated by voltage dependent inhibi-
tion (VDI) and intracellular calcium dependent inhibition (CDI).
The pore forming α1 subunit contains four domains (I–IV), each
domain consisting of six transmembrane segments (S1–S6; Cat-
terall et al., 2005; see Figure 2). S5 and S6 of all four domains form
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the central pore with S6 lining the inner surface of the pore and
occluding the pore in the inactive state. S1 to S4 from each domain
form the voltage sensing domain and on activation the S4 segment
moves outward triggering S6 movement leading to gate opening
(Swartz, 2004).
Calmodulin (CaM) binds to the IQ domain located at the C-
terminus of the pore forming α1 subunit. The formation of a
Ca2+-CaM complex results in CDI (Tadross et al., 2008). Calcium
binding to the N- and C-terminal CaM lobes can induce distinct
channel regulation (Dick et al., 2008). Recently, editing of the core
sequence of the IQ domain of Cav1.3 by ADAR2 has been discov-
ered. The core sequence comprises of the 4 amino acids IQDY.
Upon editing different isoforms such as MQDY, IRDY, MQDC,
MRDY, MRDC, or IQDC can be generated (see Figures 1 and
4). This editing event is restricted to the central nervous system
(CNS; Huang et al., 2012). Additionally, the pattern of editing is
developmentally regulated. It is negligible at e14 and prominently
increases at p4. RNA editing of the IQ domain shows spatial dis-
tribution being highest at the frontal cortex and hippocampus
(Huang et al., 2012). The MQ and IR versions show weaker CDI
while the MR variant exhibits up to 50% reduction of CDI and
faster recovery from inactivation. Reduction in CDI consequently
increases the cellular calcium load (see Table 1).
SEROTONIN 2C RECEPTOR
The mammalian 5-hydroxytryptamine receptor subtype 2C (5-
HT2c) is found widely distributed in the CNS. 5-HT2cR belongs
to the G-protein-coupled receptor superfamily that stimulates
phospholipase C (PLC) activity (Hoyer et al., 2002). The 5-HT2c
receptor interacts with the multi PDZ-domain bearing protein
(MPDZ). Both these proteins co-localize on the apical membrane
of choroid plexus cells (Drago and Serretti, 2009). The pre-mRNA
encoding serotonin receptor 5-HT2c is edited at five sites termed
A, B, C, D, and E. Editing can lead to the exchange of three amino
acids that are located within the second intracellular loop of the
receptor (see Figure 2). This region has been shown to be impor-
tant for efficient G-protein coupling (Niswender et al., 1998).
Editing at the five positions in RNA can, in principle, yield a
combination of 32 different mRNAs which encode 24 different
protein isoforms (Burns et al., 1997; Niswender et al., 1999). In
mouse brain, however, only eight major receptor variants can be
detected at significant levels. Also sequencing analysis of human
brain samples only detected 12 possible isoforms derived from
RNA editing. This suggests that not all possible combinations of
editing do exist in vivo (Wang et al., 2000; Wahlstedt et al., 2009).
Moreover, the repertoire of possible editing combinations varies
throughout development (Wahlstedt et al., 2009). Editing at sites
A and B is accomplished by ADAR1, sites C, D, and E, however, are
preferentially deaminated by ADAR2 (Hartner et al., 2004).
Upon editing, reduced G-protein coupling is observed in the
edited states (Burns et al., 1997; see Figure 1). Editing not only
reduces the constitutive activity of the receptor but also dimin-
ishes agonist potency and calcium release (Price et al., 2001). At
the cellular level, editing changes the surface expression of the
receptor. The subcellular distribution of the receptor depends on
β arrestin-2 interaction with inverse correlation to the constitutive
FIGURE 4 | Cav1.3 and calmodulin interaction. Calmodulin binds to
Cav1.3 without calcium as apoCaM at the IQ motif. Calmodulin binds to
calcium through its N-terminal and C-terminal loop and mediates
calcium dependent inhibition (CDI). Editing modifies IQ to MR and
inhibits calmodulin binding. Intracellular calcium increases in the
absence of CDI.
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activity of the receptor. Editing decreases the constitutive activity
and enhances surface expression. The fully edited VGV isoform
displays complete surface expression. The unedited INI isoforms
exhibit endosomal accumulation whereas the edited VSV isoforms
with moderate activity display vesicular and cell surface expression
(Marion et al., 2004). Editing also modulates the expression of the
receptor through splicing. Unedited 5-HT2c transcripts result in a
splice version that yields a shorter protein, while edited transcripts
form the full length receptor (Flomen et al., 2004). However, the
underlying factors resulting in alternative splicing are still not
entirely clear. It was shown, for instance, that the human and
mouse C/D box snoRNAs HBII-52 and MBII-52, respectively, can
inhibit site C editing via base-pairing (Vitali et al., 2005). This base-
pairing event also seemingly masks a silencer element important
for the regulation of splicing (Kishore and Stamm, 2006).
The serotonin 2c receptors can also activate extracellular
signal-regulated kinase (ERK) independent of G-protein coupling.
Expression of the unedited INI isoform increases ERK1/2 phos-
phorylation in transfected HEK293 cells while expression of the
edited VGV form decreases phosphorylation. However, this activa-
tion is significantly reduced upon β-arrestin depletion (Labasque
et al., 2010). Editing also decreases downstream ERK signaling.
Consistently, a shift toward the edited isoforms leads to reduced
ERK signaling in prefrontal cortex of ADAR2 transgenic mice
(Singh et al., 2011). Overexpression of ADAR2 and hyperediting
of the 5-HT-2c receptor is also correlated with depressive behavior
(Singh et al., 2009).
Mice carrying either a completely unedited “INI” version or
a completely edited “VGV” version of the 5-HT-2c receptor have
been generated (Kawahara et al., 2008). While the INI mice grow
normally but are rather immobile in a forced swim assay, resem-
bling a depressive behavior (Mombereau et al., 2010). It has also
been shown that a decrease in the INI form of the receptor can lead
to a decrease in ERK1/2 phosphorylation in transgenic ADAR2
mice (Singh et al., 2011). Aberrant ERK1/2 phosphorylation in
turn is linked to depression and suicidal behavior as ERK1/2 plays
a critical role in synaptic plasticity (Dwivedi et al., 2009).
Mice expressing the fully edited VGV version of the recep-
tor, in contrast, have reduced fat mass, growth retardation, and
high energy expenditure most likely due to hyperactivation of the
sympathetic nervous system (Kawahara et al., 2008). Mutant mice
with fully edited VGV isoforms have also been shown to display
symptoms resembling those of the Prader–Willi syndrome (PWS;
Morabito et al., 2010).
Thus, data from transgenic mice clearly demonstrate that
the editing status of 5-HT2c-R can directly influence behavior
underscoring the importance of RNA editing for the etiology of
psychiatric disorders.
ACTIN ORGANIZATION BY FILAMINS
Two actin cross-linking proteins Filamin A (FLNa) and Filamin B
(FLNb) are amongst a group of newly identified mammalian edit-
ing targets (Levanon et al., 2005; Nishimoto et al., 2008; Li et al.,
2009). The two 280 kDa proteins form homo- and heterodimers
and mediate orthogonal branching of actin filaments (Fucini et al.,
1997; Sheen et al., 2002; Popowicz et al., 2006). Mammalian fil-
amins are built of 24 immunoglobulin (Ig) like repeats divided
into two rod segments. Rod 1 consisting of repeats 1–15 interacts
with actin filaments whereas rod 2 is built from repeats 16–23
and interacts with several proteins (Chen et al., 2011). Repeat 24
is required for dimerization. Actin reorganization is essential for
cell motility and migration and is an important determinant in
dendritic spine and synapse formation (Dillon and Goda, 2005;
Popowicz et al., 2006). Depletion of FLNa leads to embryonic
lethality with severe cardiovascular and bone development defects
(Feng et al., 2006; Hart et al., 2006). Also FLNb deficient mice show
defective microvasculature and bone malformation (Zhou et al.,
2007). Editing of FLNa or FLNb leads to a conserved glutamine
(Q) to arginine (R) codon exchange in repeat 22 (Li et al., 2009)
that is developmentally regulated (Wahlstedt et al., 2009). Repeat
22 has been shown to be involved in the interaction with a broad
range of proteins (Popowicz et al., 2006; see Table 1).
FLNa interacts with the C-terminus of the metabotrobic glu-
tamate receptor mGlu5a, 5b, 7b, and 8a (see Figure 1). Moreover,
low affinity binding was also detected for mGlu4a and mGlu7a.
Repeats 21 and 22of FLNa harboring the edited amino acid
represent the minimal region critical for this interaction (Enz,
2002). Editing may thus regulate this interaction, the potential
consequences of which remain to be determined.
FLNa also interacts with potassium channel Kv4.2 at filipodial
roots and shows overlapping expression in cortical and hippocam-
pal neurons. A “PTPP” amino acid motif in Kv4.2 (AA 601–604) is
critical for this interaction. Again, FLNa repeats 21–24 are involved
in this interaction. Coexpression of filamin in heterologous cells
enhances the whole cell current density by∼2.7-fold most likely by
properly positioning functional KV4.2 receptors at the cell surface
(Petrecca et al., 2000).
Presenilins (PS) belong to a conserved protein family that were
the first proteins identified responsible for familial Alzheimer
disease (FAD; Nelson et al., 2010). Presenilins harbor eight trans-
membrane domains. PS1 and PS2 were identified in a yeast two
hybrid assay to interact with repeats 21–24 of FLNa. A region
between TM6 and TM7 of the presenilins is responsible for this
interaction. The same loop harbors 14 different mutations that
are associated with FAD. FLNa and PS1 co-localize in astrocytes
(Zhang et al., 1998). Moreover, overexpression of PS1 in cultured
HEK293 cells redistributes FLN from the cell periphery to the
cytoplasm. The FAD-linked mutation PS1M146L induces FLNa
expression (Lu et al., 2010). The FLNa PS1interactionis well con-
served and could be physically and genetically demonstrated in
Drosophila melanogaster (Guo et al., 2000).
FLNa also co-localizes with the neuronal microtubule associ-
ated protein Tau. Tau is involved in polymerization and stability
of microtubules. Tau protein is abnormally phosphorylated and
forms neurofibrillary tangles in the hippocampus in Alzheimer
patients. It is believed that Tau induced FLNa depletion leads to
actin network destabilization and consequently to synaptic loss
(Feuillette et al., 2010).
The functional implication of editing-induced Q2341R amino
acid exchange in repeat 22of FLNa is still unknown. However, it
may have an effect on a broad range of interactions (Chen et al.,
2011). One example is the interaction of FLNa with β-integrin.
Repeat 21 cannot interact with β-integrin unless repeat 20 disasso-
ciates from it (Lad et al., 2007). Similarly, FLNa editing may change
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neuronal receptor organization as well as synaptic transmission by
altering the interaction profile with binding partners.
CYTOPLASMIC FMRP INTERACTING PROTEIN 2 (CyFIP2)
CyFIP2 was identified as an interaction partner of the fragile X
mental retardation protein (FMRP) in a yeast two hybrid screen.
The region of interaction between CyFIP2 and FMRP overlaps
with the FMRP dimerization site (Schenck et al., 2001). CyFIP2
also interacts with FMRP-related proteins FXR1P and FXR2P
(Schenck et al., 2001). The CyFIP2 encoding pre-mRNA is pri-
marily edited by ADAR2 introducing a single K320Eamino acid
exchange in mouse and human CyFIP2 (Levanon et al., 2005;
Nishimoto et al., 2008).
CyFIP2 is a member of the WAVE/SCAR complex and is
involved in actin remodeling. It plays a pivotal role in neuronal
wiring as it directly interacts with FMRP and Rac-1 (Schenck
et al., 2003). Flies have a single Cyfip gene which is 67% identical
to human CyFIP1 and CyFIP2. Mutant Cyfip flies display shorter
synapses and profound axonal path finding, growth, and branch-
ing defects (Schenck et al., 2003, 2004). CyFIP2 is mainly involved
in maintaining synaptic plasticity as it is involved in translational
regulation impeded in fragile X mental retardation. In verte-
brates like Zebrafish that harbor both CyFIP1 and CyFIP2, cyfip2
mutants exhibit dorso-nasal axonal pathfinding defects (Pittman
et al., 2010). RNAi of CyFIP2 in murine melanoma cells leads to
aberrant lamellipodia proving the functionality of Cyfip2 in actin
remodeling and cell motility (Steffen et al., 2004).
Editing at the K/E position of CyFIP2 increases during mouse
brain development ranging from 4% at e15 to 75% editing at p21
(Wahlstedt et al., 2009). However, there seems a significant decline
in CyFIP2 editing with age in human brain (Nicholas et al., 2010).
The biological significance of Cyfip2 editing is currently not
clear. One possibility would be that the migratory behavior of cells
is regulated by CyFIP2 by antagonizing Rac-1. However, interac-
tions with FMR1 or the nucleo-cytoplasmic shuttling of Cyfip2
might equally be affected by editing. With the new discovery of
modulation of ADAR by FMR1 in flies the possibility of a feed
back loop of CyFip2 and ADAR regulation also appears possible
as Cyfip antagonizes FMR1 in flies (Schenck et al., 2003).
HU PROTEINS
Hu proteins are RNA-binding proteins which play an essential
role in neuronal differentiation and plasticity. HuB, HuC, and Hu
D are neuron specific whereas HuR is associated with cell stress
responses. Each Hu protein has three RNA recognition motifs
(RRM1–3). Hu proteins preferentially bind to AU rich RNA ele-
ments (ARE) where they can act as RNA stabilizers and regulators
of polyadenylation and translation (Mobarak et al., 2000; Zhu
et al., 2006; Hinman and Lou, 2008). Recently, five editing sites
were discovered in HuD and HuB in a bioinformatic screen of
deep-sequencing data (Enstero et al., 2010). The functional impli-
cation of editing is unknown. However, it is likely that editing of
Hu proteins can alter the landscape of the brain transcriptome
(Paz-Yaacov et al., 2010).
NOVA-1
Recently, another RNA-binding protein, NOVA-1, was found to be
edited (Irimia et al., 2012). NOVA-1 is a key regulator of alternative
splicing of RNAs encoding synaptic proteins involved in neuronal
activity in the CNS. NOVA-1 binds pre-mRNAs in a sequence
dependent manner and diversifies proteins by splicing regulation.
Nova-1 null mice die postnatally from motor neuron death due to
spinal and brainstem neuron apoptosis (Jensen et al., 2000). The
splicing regulation by NOVA-1/2 is well conserved from mam-
mals to insects. Both Nova-1/2 and the Drosophila melanogaster
ortholog PASILLA (PS) binds to YCAY enriched regions located
upstream of repressed exons and downstream of activated exons
(Brooks et al., 2011). RNA editing increases the Nova-1 half life
by decreasing its susceptibility to proteasome degradation (Irimia
et al., 2012). This stabilization of Nova-1 by RNA editing can cre-
ate another layer of complexity in diversification of brain specific
transcripts.
Dysregulation of A to I editing has been found associated with
a number of diseases, ranging from mental disorders to cancers
(Paz et al., 2007). The following sections will give an overview on
diseases that are strongly influenced by ADAR-mediated editing.
ASTROCYTOMA
This glial cell tumor is classified on the basis of malignancy into
four grades (I–IV). Glioblastomamultiforme (GBM) is a grade IV
tumor with a survival rate of less than 18 months in children and
adults (Stupp et al., 2005). Glial cells respond to external stimuli via
neuronal receptors (Bergles et al., 2000; Gallo and Ghiani, 2000).
Hypoediting of GluA2 at the Q/R site has been observed in GBM
leading to increased Ca2+ influx and activation of the Akt pathway
through phosphorylation (Ishiuchi et al., 2007). Also in pediatric
astrocytoma the malignancy increases with a decrease in editing.
GBM cells show strong migratory activity which is reduced upon
ADAR2 expression. Furthermore a decrease in GluK2 editing at the
I/V and Y/C sites is observed in different brain regions (Cenci et al.,
2008). Since both GluA2 and GluK2 are edited by ADAR2, ADAR2
overexpression strongly inhibits cell proliferation and slows down
the cell cycle. Mutation in the ADAR2 deaminase domain does not
affect tumor malignancy proving the necessity of editing in tumor
progression (Cenci et al., 2008). In this type of tumor ADAR2 is
expressed at a normal level, while ADAR1 and ADAR3 are over-
expressed leading to the assumption that higher concentrations
of ADAR1 and ADAR3 may inhibit the activity of ADAR2 (Cenci
et al., 2008).
In pediatric astrocytoma high levels of interferon induced
ADAR1 p150 are found. Overexpression of ADAR1 might again
interfere with ADAR2 activity (Chen et al., 2000; Cenci et al., 2008).
AMYOTROPHIC LATERAL SCLEROSIS
Amyotrophic Lateral Sclerosis (ALS) is characterized by slow
degeneration of upper and lower motor neurons with a conse-
quent loss of voluntary movement (Rothstein, 2009). Different
mechanisms are proposed to be the underlying causes of this
disease. Decreased editing at the Q/R site leading to increased
Ca2+ influx has been observed in mice displaying late onset
ALS (Kuner et al., 2005). The editing efficiency at the GluA2
Q/R site also decreases dramatically in ALS patients (Kawahara
et al., 2004). Consistent with reduced Q/R site editing, a sig-
nificant decrease in ADAR2 expression has been observed in
spinal motor neurons of ALS patients (Hideyama et al., 2011).
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However, no decline in editing of Q/R in upper motor neurons
was observed.
Additionally, the flip-flop alternative splicing pattern of GluA2,
downstream of the R/G editing site is pushed toward flip-bearing
transcripts in ALS patients (Kawahara and Kwak, 2005). The flip
form of GluA2 promotes assembly of slowly desensitizing AMPA
receptors (Tomiyama et al., 2002).
Clearing of glutamate from the synaptic cleft is accomplished
through glutamate transporters that prevent repeated firing and
excitotoxicity. The astroglial EAAT2 glutamate transport is respon-
sible for clearing glutamate from the cleft. ALS patients show
50% decreased EAAT2 protein levels as editing generates a cryp-
tic polyadenylation site leading to intron 7 retention (Flomen and
Makoff, 2011). Depletion of EAAT2 leads to neuronal death in
transgenic mice (Rothstein et al., 1996).
PRADER–WILLI SYNDROME
The Prader–Willi locus is genomically imprinted and only
expressed from the paternally inherited chromosome, while the
maternal copy is transcriptionally silenced (Constancia et al.,
2004). Loss of expression or mutation of the paternal 15q11–
q13 locus therefore leads to the formation of the Pader–Willi
disease phenotype. Patients have growth defects in both sexes
due to growth hormone deficiency, and cognition problems (But-
ler, 2011). Amongst several other transcripts the small C/D
box snoRNA MBII-52 is located within the Prader–Willi locus.
This snoRNA contains 18 nucleotides that are complementary
to the editing site C of the serotonin 5-HT2c receptor. When
expressed in nucleoli the 5-HT2c pre-mRNA can even be tar-
geted for 2′-O-methylation (Vitali et al., 2005). Loss of MBII-
52 causes an increase in editing. Mice with a deleted PWS
imprinted control region show enhanced locomotor activity and
aberrant discriminative behavior (Doe et al., 2009). Altered 5-
HT2CR editing can also lead to phenotypes that mimic PWS.
Mice expressing the fully edited VGV form of the serotonin
receptor also exhibit PWS-like phenotypes such as hyperpha-
gia, hypotonia, increased metabolism, and slim stature (Mora-
bito et al., 2010). Molecularly, this isoform exhibits blunted
G-protein coupling, reduced constitutive activity and enhanced
serotonergic neurotransmission possibly as a consequence of
increased surface expression (Kawahara et al.,2008; Morabito et al.,
2010).
TRANSIENT FOREBRAIN ISCHEMIA
Cerebral ischemia in CA1 pyramidal neurons is caused by reduced
oxygen supply, primarily as a consequence of heart attacks or
occlusions of arteries. Neuronal damage is caused due to increased
Ca2+ influx because of increased GluA2Q expression (Liu et al.,
2004). Increase in calcium activates Cdk5 which phosphory-
lates NMDA receptors (Liu et al., 2004). Phosphorylation, in
turn, prolongs opening of NMDA receptors which can activate
nitric oxide synthase leading to the formation of toxic perox-
ynitrite that induces neuronal death (Fiskum et al., 1999; Bossy-
Wetzel et al., 2004). During experimental induction of ischemia
in rat brain ADAR2 expression is reduced. Consistently, recovery
from ischemia can be accomplished through increased ADAR2
expression (Peng et al., 2006).
Downregulation of R/G site editing has been observed dur-
ing spinal cord injury (SCI). Reduced editing at this site may
limit cell death progression by suppressing postsynaptic exci-
tation. Thus, editing might influence recovery after SCI (Bar-
bon et al., 2010). Reduced editing at the R/G site was also
observed in rat prefrontal cortex upon treatment with phency-
clidene (PCP) that instigates schizophrenia like behavior (Barbon
et al., 2007).
EPILEPSY
Epilepsy is a common neurological disorder characterized by
seizures caused by neuronal hyperexcitability (Bozzi et al., 2012).
Decreased editing of the AMPA receptor Q/R site leads to calcium
permeable channels. Mice heterozygous for an editing deficient
GluA2 allele develop seizures and die at 3 weeks of age while
complete absence of GluA2 expression does not provoke seizures
(Brusa et al., 1995).
Increased editing at the R/G site of the GluA2 transcripts and
also of Kv1.1 have also been linked to seizures (Vollmar et al.,
2004). Editing at the R/G site enhances glutamate response of
the receptor and modulates neuronal excitability (Lomeli et al.,
1994). The editing-induced I/V change in Kv1.1 channels lies in
the S6 segment. This is the target site of many drugs blocking the
channel (Decher et al., 2010). Interestingly, the Kv channel blocker
4-aminopyridine (4-AP) also induces seizure like events in rats.
RNA editing, in turn, reduces the affinity of 4-AP and serves as a
compensatory mechanism against epileptic seizures (Streit et al.,
2011).
PSYCHIATRIC DISORDERS
Changes in the editing pattern of 5-HT2C pre-mRNA have been
linked to different psychiatric disorders such as schizophrenia,
depression, and bipolar disorder (Table 1). Editing leads to
reduced G-protein activation resulting in decreased basal activ-
ity (Niswender et al., 1999). However, the observed correlations
do not allow a clear-cut conclusion. Sample sizes are typically
small and the investigated samples are rarely well controlled and
matched, therefore giving a heterogeneous picture. For instance,
overexpression of the edited VSV receptor isoform has been
observed in patients suffering from schizophrenia and bipolar dis-
orders (Dracheva et al., 2008). Previously, in two different studies
on suicide victims suffering schizophrenia, a significantly under
edited B site and a hyper edited A site has been observed (Niswen-
der et al., 2001; Sodhi et al., 2001). Analysis on suicide victims
suffering major depression, in contrast, revealed an increase in
editing at the C and C′ site accompanied by decreased D site
editing. Treatment with fluoxetine, a serotonin selective uptake
inhibitor, causes opposing effects on editing of these sites indicat-
ing site specific serotonin dependent regulation (Gurevich et al.,
2002). Deregulation of A to I editing in schizophrenia and bipo-
lar disorder (type I) patients and underediting of I/V site in
GRIK2 resulting in high calcium influx has also been related
to over expression of ADAR2 isoforms with diminished cat-
alytic activity (Silberberg and Ohman, 2011; Silberberg et al.,
2012). However, increase in ADAR1 expression has also been
suggested as an inhibitor of ADAR2 activity (Simmons et al.,
2010).
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OUTLOOK
Current studies on RNA editing have clearly shown that adeno-
sine deamination is most abundant in the CNS where it plays a
major role in the diversification of the transcriptome. Three major
processes seem to be primarily affected by A to I editing: first, many
receptors and channels are modulated in their primary response
and sensitivity to stimuli. Second, in many cases receptor assem-
bly and retention in the ER seems to be affected by RNA editing.
Finally, cytoskeletal components required for both outgrowth of
neurons but also to the structuring of the cortical cytoskeleton
and the anchoring of receptors is affected by RNA editing. It is
one of the challenges to understand how these three processes are
interconnected possibly being regulated through neuronal activity
that may feed back on the process of RNA editing itself.
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